Here we list 5 signs of increased uric acid seen in body and what you can do about it 1. Joint pain and swellingOne of the most common signs of high uric acid is sudden joint pain, especially in the ...

Her general practitioner diagnosed gouty arthritis because of a high serum uric-acid level (600 µmol/l; normal range 270–380 µmol/l) coexistent with tophi in her hands, and initiated ...

Background Although typically a late feature of gout, tophi may present early in the course of disease. The aim of this study was to identify factors associated with the presence of early ...

This study demonstrates that gout patients from the US and three EU countries suffer from significantly decreased HRQOL, with the average patient suffering decreased mental as well as physical ...

Gout in foot joints is most common, with gout often affecting the big toe joint. However, ... If you have untreated gout for a long time, something called tophi can develop.

Asymptomatic hyperuricemia: During this stage, uric acid builds up in your blood but doesn't yet cause symptoms.; Acute gout: Uric acid crystals start building up in a joint, causing severe pain and ...

The Food and Drug Administration (FDA) has granted Fast Track designation to AR882 for the treatment of clinically visible tophi in patients with gout. AR882 is an investigational selective uric ...

Publish Date August 20, 2024 . AR882 is an investigational selective uric acid transporter 1 inhibitor.

Arthrosi Therapeutics, Inc., a late-stage biotechnology company developing a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to treat gout, today announced ...

Arthrosi to present positive phase 2 data for its novel selective URAT1 inhibitor AR882 in patients with tophaceous gout at ACR convergence 2023. News release. Arthrosi Therapeutics. November 7, 2023.

PRINCETON, N.J., Aug. 5, 2024 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a groundbreaking treatment for refractory and tophaceous gout patients, today announced full ...

PRINCETON, N.J., Aug. 5, 2024 /PRNewswire/ -- Shanton Pharma, a clinical-stage biotech company developing a groundbreaking treatment for refractory and tophaceous gout patients, today announced ...